Compare VIR & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ERII |
|---|---|---|
| Founded | 2016 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 850.2M |
| IPO Year | 2019 | 2008 |
| Metric | VIR | ERII |
|---|---|---|
| Price | $8.40 | $9.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $19.63 | $16.50 |
| AVG Volume (30 Days) | ★ 3.5M | 994.9K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | 5.00 |
| EPS | N/A | ★ 0.42 |
| Revenue | $68,556,000.00 | ★ $134,987,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,049.62 | $20.55 |
| P/E Ratio | ★ N/A | $23.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $9.35 |
| 52 Week High | $10.91 | $18.31 |
| Indicator | VIR | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 31.69 |
| Support Level | $5.14 | $9.47 |
| Resistance Level | $10.29 | $14.78 |
| Average True Range (ATR) | 0.47 | 0.40 |
| MACD | -0.18 | 0.12 |
| Stochastic Oscillator | 3.20 | 26.88 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.